Hashem Koohy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hashem Koohy has a total of 279 co-authors. Here are the top co-authors by number of shared publications:
- Alison Simmons
Medical Research Council Translational Immune Discovery Unit (MRC TIDU), Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, UK
12 shared publications - Agne Antanaviciute
Medical Research Council Translational Immune Discovery Unit (MRC TIDU), Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, UK
10 shared publications Agne Antanaviciute
Medical Research Council Translational Immune Discovery Unit (MRC TIDU), Weatherall Institute of Molecular Medicine, University of Oxford, United Kingdom
7 shared publications- Graham Stuart Ogg
CAMS Oxford Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, University of Oxford, United Kingdom
6 shared publications Alison Simmons
Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine (WIMM), John Radcliffe Hospital, University of Oxford , Oxford , UK
5 shared publicationsChloe H. Lee
MRC Human Immunology Unit, Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine (WIMM), John Radcliffe Hospital, University of Oxford
5 shared publications
Latest Publications
- Open Access
Beyond Better Models: Barriers and a Path Forward in Generalisable TCR–Antigen Specificity Prediction
T cells are at the centre of adaptive immunity, protecting the organism against infection and cancer. T-cell receptors (TCRs), expressed on the surface of T cells, enable the recognition of target cells through interactions with peptides presented by major histocompatibility complex (pMHC) molecules. Reliable, large-scale mapping of TCRs to their cognate pMHCs remains a holy grail of modern systems immunology, with far-reaching implications for cancer immunotherapy, vaccine development, and the understanding and treatment of autoimmune diseases. While exhaustive experimental mapping remains intractable due to the enormous combinatorial sequence space of TCRs and pMHCs, computational approaches offer a promising alternative. Consequently, we have witnessed increasingly sophisticated computational models of TCR–antigen specificity, from small neural networks to deep generative models and large protein language models. However, several independent benchmarks have shown that these models, despite their size and sophistication, largely fail to generalise to TCRs or pMHCs not present in the data available during model development. Here, we investigate possible reasons for this and suggest a path forward to generalisable TCR–pMHC prediction. First, our analysis of the largest public repositories of TCR–pMHC data reveals significant biases towards a small number of antigens and MHC molecules, sparse sampling of TCR sequence space per pMHC, as well as inconsistencies and inaccuracies in data collation. Second, we show the importance of carefully setting up model evaluation to measure discrimination based on antigen specificity instead of confounding factors present in the evaluation data. Finally, we highlight the need for and propose how best to match the evaluation metric with the specific downstream application of the predictions. Our investigation suggests that we, as a community, need more representative and better curated data, and a robust set of metrics and benchmarks to guide future model development towards generalisable TCR–pMHC specificity prediction.
Open AccessBeyond Better Models: Barriers and a Path Forward in Generalisable TCR–Antigen Specificity Prediction
T cells are at the centre of adaptive immunity, protecting the organism against infection and cancer. T-cell receptors (TCRs), expressed on the surface of T cells, enable the recognition of target cells through interactions with peptides presented by major histocompatibility complex (pMHC) molecules. Reliable, large-scale mapping of TCRs to their cognate pMHCs remains a holy grail of modern systems immunology, with far-reaching implications for cancer immunotherapy, vaccine development, and the understanding and treatment of autoimmune diseases. While exhaustive experimental mapping remains intractable due to the enormous combinatorial sequence space of TCRs and pMHCs, computational approaches offer a promising alternative. Consequently, we have witnessed increasingly sophisticated computational models of TCR–antigen specificity, from small neural networks to deep generative models and large protein language models. However, several independent benchmarks have shown that these models, despite their size and sophistication, largely fail to generalise to TCRs or pMHCs not present in the data available during model development. Here, we investigate possible reasons for this and suggest a path forward to generalisable TCR–pMHC prediction. First, our analysis of the largest public repositories of TCR–pMHC data reveals significant biases towards a small number of antigens and MHC molecules, sparse sampling of TCR sequence space per pMHC, as well as inconsistencies and inaccuracies in data collation. Second, we show the importance of carefully setting up model evaluation to measure discrimination based on antigen specificity instead of confounding factors present in the evaluation data. Finally, we highlight the need for and propose how best to match the evaluation metric with the specific downstream application of the predictions. Our investigation suggests that we, as a community, need more representative and better curated data, and a robust set of metrics and benchmarks to guide future model development towards generalisable TCR–pMHC specificity prediction.
- Open Access
Distinct transcriptional states of draining lymph node T cells following influenza vaccination in individuals with underrepresented ancestries
The transcriptional and cell repertoire changes of lymph node (LN) T cells following influenza vaccination have been under-investigated across different ethnicities. Draining (dLN) and non-draining (ndLN) axillary LN cells from 17 participants with genotypically varied African or Asian ancestry ( ISRCTN13657999 ) were collected by fine needle aspiration (FNA) before, 5 days and 42 days after adjuvanted influenza vaccination and analysed by single-cell RNA-sequencing (scRNA-seq). The early dLN transcriptional profile and cellular dynamics were distinct from the ndLN; BACH2 expressing T cells were highly induced, exhibiting stem-like and unique quiescence signatures. Proliferating T follicular helper cells (Tfh) were enriched in dLN and Th1-like Tfh predominated with highly induced transcriptional changes. The BACH2 + T cell state and Th1-like Tfh cells, transcriptionally distinct from germinal centre (GC) T cells, were co-localised with LAMP3 + dendritic cells in the T cell zone of publicly available LN datasets, a region that was also distinct from GC Tfh niches. Together, these findings indicate that the induction of a robust, proliferative, and transcriptionally diverse Tfh response, alongside a discrete subset of BACH2 + T cells, represents a marked feature of the early T cell zone immune response to adjuvanted influenza vaccine in the dLN.
Open AccessDistinct transcriptional states of draining lymph node T cells following influenza vaccination in individuals with underrepresented ancestries
The transcriptional and cell repertoire changes of lymph node (LN) T cells following influenza vaccination have been under-investigated across different ethnicities. Draining (dLN) and non-draining (ndLN) axillary LN cells from 17 participants with genotypically varied African or Asian ancestry ( ISRCTN13657999 ) were collected by fine needle aspiration (FNA) before, 5 days and 42 days after adjuvanted influenza vaccination and analysed by single-cell RNA-sequencing (scRNA-seq). The early dLN transcriptional profile and cellular dynamics were distinct from the ndLN; BACH2 expressing T cells were highly induced, exhibiting stem-like and unique quiescence signatures. Proliferating T follicular helper cells (Tfh) were enriched in dLN and Th1-like Tfh predominated with highly induced transcriptional changes. The BACH2 + T cell state and Th1-like Tfh cells, transcriptionally distinct from germinal centre (GC) T cells, were co-localised with LAMP3 + dendritic cells in the T cell zone of publicly available LN datasets, a region that was also distinct from GC Tfh niches. Together, these findings indicate that the induction of a robust, proliferative, and transcriptionally diverse Tfh response, alongside a discrete subset of BACH2 + T cells, represents a marked feature of the early T cell zone immune response to adjuvanted influenza vaccine in the dLN.
- Open Access
- 8 September 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
CD1a-autoreactive T-cell sensing of skin barrier compromise
Background: T cells are often enriched at barrier tissues, yet little is known about their roles in barrier sensing and relevance to associated disease. CD1a is a major histocompatibility complex class I-like molecule expressed by Langerhans cells, and forms complexes with lipid antigens to facilitate recognition by nonclassical CD1a-reactive T cells. Objectives: To investigate the role of CD1a in the disease pathogenesis of atopic dermatitis (AD). Methods: Human skin challenge, single-cell and spatial transcriptomic-based approaches and functional immunology were used to assess the role of CD1a in AD pathogenesis. Results: Skin allergen challenge in individuals with AD induced skin CCL17 and CCL22 concentrations that promoted CCR4+ T-cell migration. Single-cell resolution proteo-transcriptomics from human lesional AD skin tissue identified a dominant CCL17/CCL22 source as a persistent population of activated skin CD1a+ dendritic cells (DCs) previously shown to be transiently enriched in human skin wounds. Single-cell resolution spatial tissue analyses showed that these cells were predominantly located within lesional subepidermal microcompartment clusters co-localizing with distinct subpopulations of T helper 2 (Th2) cells. Activated skin DCs expressed neutral sphingomyelinase, which processed inhibitory long-chain sphingomyelin to drive Th2 cell CD1a autoreactivity. Conclusions: The findings are consistent with human CD1a-autoreactive T cells sensing chronic skin barrier compromise through the detection of altered sphingomyelin cycle activity, with implications for the pathogenesis of atopic and related disease.
- 8 September 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Open AccessCD1a-autoreactive T-cell sensing of skin barrier compromise
Background: T cells are often enriched at barrier tissues, yet little is known about their roles in barrier sensing and relevance to associated disease. CD1a is a major histocompatibility complex class I-like molecule expressed by Langerhans cells, and forms complexes with lipid antigens to facilitate recognition by nonclassical CD1a-reactive T cells. Objectives: To investigate the role of CD1a in the disease pathogenesis of atopic dermatitis (AD). Methods: Human skin challenge, single-cell and spatial transcriptomic-based approaches and functional immunology were used to assess the role of CD1a in AD pathogenesis. Results: Skin allergen challenge in individuals with AD induced skin CCL17 and CCL22 concentrations that promoted CCR4+ T-cell migration. Single-cell resolution proteo-transcriptomics from human lesional AD skin tissue identified a dominant CCL17/CCL22 source as a persistent population of activated skin CD1a+ dendritic cells (DCs) previously shown to be transiently enriched in human skin wounds. Single-cell resolution spatial tissue analyses showed that these cells were predominantly located within lesional subepidermal microcompartment clusters co-localizing with distinct subpopulations of T helper 2 (Th2) cells. Activated skin DCs expressed neutral sphingomyelinase, which processed inhibitory long-chain sphingomyelin to drive Th2 cell CD1a autoreactivity. Conclusions: The findings are consistent with human CD1a-autoreactive T cells sensing chronic skin barrier compromise through the detection of altered sphingomyelin cycle activity, with implications for the pathogenesis of atopic and related disease.
- Open Access
Characterising AlphaFold 3’s ability to predict T cell antigen specificity
T cells are a key part of the adaptive immune system. Using their surface-bound T cell antigen receptors (TCRs), these cells scan peptides and other antigens presented to them by major histocompatibility complex molecules (MHCs) on the surface of cells, searching for abnormalities. Although determining the map between TCRs and their target antigens is of vital importance for the design of safe and effective T cell-based vaccines and therapeutics, decoding these interactions is challenging. Experimental methods are not scalable, and sequence-based computational methods have issues generalising to new antigens. The IMMREP25 benchmark of methods for predicting T cell antigen specificity showed that AlphaFold-based methods promise improved generalisation to novel antigens. However, the ability of structure prediction models to predict T cell antigen specificity has not been robustly evaluated previously. In this work, we characterise AlphaFold’s ability to predict T cell antigen specificity. We created a pipeline for high-throughput prediction of TCR:peptide-MHC (pMHC) structures using AlphaFold that is > 100 fold faster than the default implementation and used it to benchmark AlphaFold 3 (AF3) and similar models at predicting T cell antigen specificity. We investigated the underlying correlates of AlphaFold-derived binding scores and found that the model’s predictive power is related to the positioning of TCRs over the pMHC and not chemical interactions. Furthermore, we refine the AlphaFold-derived binding scores by training a machine learning model we call the PAE Aggregator. We then investigate AF3’s ability to uncover the clustering rules of TCR repertoires and recapitulate mutational scanning experiments. These analyses show that AlphaFold3 clusters sequence-similar TCRs according to their binding mode and detects disrupting point mutations accurately. Our results highlight both the promise and the current limitations of structure-based approaches for predicting TCR specificity, guiding the development of more reliable immunological prediction methods.
Open AccessCharacterising AlphaFold 3’s ability to predict T cell antigen specificity
T cells are a key part of the adaptive immune system. Using their surface-bound T cell antigen receptors (TCRs), these cells scan peptides and other antigens presented to them by major histocompatibility complex molecules (MHCs) on the surface of cells, searching for abnormalities. Although determining the map between TCRs and their target antigens is of vital importance for the design of safe and effective T cell-based vaccines and therapeutics, decoding these interactions is challenging. Experimental methods are not scalable, and sequence-based computational methods have issues generalising to new antigens. The IMMREP25 benchmark of methods for predicting T cell antigen specificity showed that AlphaFold-based methods promise improved generalisation to novel antigens. However, the ability of structure prediction models to predict T cell antigen specificity has not been robustly evaluated previously. In this work, we characterise AlphaFold’s ability to predict T cell antigen specificity. We created a pipeline for high-throughput prediction of TCR:peptide-MHC (pMHC) structures using AlphaFold that is > 100 fold faster than the default implementation and used it to benchmark AlphaFold 3 (AF3) and similar models at predicting T cell antigen specificity. We investigated the underlying correlates of AlphaFold-derived binding scores and found that the model’s predictive power is related to the positioning of TCRs over the pMHC and not chemical interactions. Furthermore, we refine the AlphaFold-derived binding scores by training a machine learning model we call the PAE Aggregator. We then investigate AF3’s ability to uncover the clustering rules of TCR repertoires and recapitulate mutational scanning experiments. These analyses show that AlphaFold3 clusters sequence-similar TCRs according to their binding mode and detects disrupting point mutations accurately. Our results highlight both the promise and the current limitations of structure-based approaches for predicting TCR specificity, guiding the development of more reliable immunological prediction methods.
- Open Access
- 1 January 2026
- Published by Science Exploration Press
- Vol. 1 (3) , 202619
Predicting spatial transcriptomics from histology images: Progress, challenges, and directions
Spatial transcriptomics (ST) maps gene expression within intact tissues, but its cost and technical complexity limit broad adoption. A growing body of deep-learning methods now seeks to infer ST directly from routine histology images, especially hematoxylin and eosin (H&E)-stained slides, with the aim of turning archived pathology material into virtual molecular data. This review examines more than 40 ST prediction models, comparing their data requirements, modelling strategies, evaluation practices, and translational potential. Recent advances in model architecture, histology foundation models, and higher-resolution in situ ST platforms have improved prediction performance and expanded the range of potential applications. However, most current methods still show limited robustness and generalisability, with performance constrained primarily by the quantity, quality, and diversity of available ST training data. Comparisons between models also remain difficult due to inconsistent pre-processing pipelines, training datasets and evaluation strategies. The field is increasingly recognising that progress depends not only on more sophisticated models, but also on standardised benchmarks, improved data harmonisation and clearer evaluation frameworks. Despite these limitations, ST prediction is already showing utility in research settings, including biomarker discovery, tissue domain inference, molecular super-resolution and large-scale analysis of archived histology cohorts. Emerging applications also include patient stratification, virtual molecular profiling and multi-modal pathology systems that integrate histology, transcriptomics and language models. As datasets continue to expand and models become more reliable, ST prediction has the potential to become an important component of next-generation digital pathology workflows.
- 1 January 2026
- Published by Science Exploration Press
- Vol. 1 (3) , 202619
Open AccessPredicting spatial transcriptomics from histology images: Progress, challenges, and directions
Spatial transcriptomics (ST) maps gene expression within intact tissues, but its cost and technical complexity limit broad adoption. A growing body of deep-learning methods now seeks to infer ST directly from routine histology images, especially hematoxylin and eosin (H&E)-stained slides, with the aim of turning archived pathology material into virtual molecular data. This review examines more than 40 ST prediction models, comparing their data requirements, modelling strategies, evaluation practices, and translational potential. Recent advances in model architecture, histology foundation models, and higher-resolution in situ ST platforms have improved prediction performance and expanded the range of potential applications. However, most current methods still show limited robustness and generalisability, with performance constrained primarily by the quantity, quality, and diversity of available ST training data. Comparisons between models also remain difficult due to inconsistent pre-processing pipelines, training datasets and evaluation strategies. The field is increasingly recognising that progress depends not only on more sophisticated models, but also on standardised benchmarks, improved data harmonisation and clearer evaluation frameworks. Despite these limitations, ST prediction is already showing utility in research settings, including biomarker discovery, tissue domain inference, molecular super-resolution and large-scale analysis of archived histology cohorts. Emerging applications also include patient stratification, virtual molecular profiling and multi-modal pathology systems that integrate histology, transcriptomics and language models. As datasets continue to expand and models become more reliable, ST prediction has the potential to become an important component of next-generation digital pathology workflows.
- Open Access
- 2 December 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1491656
Quantifying conformational changes in the TCR:pMHC-I binding interface
Background: T cells form one of the key pillars of adaptive immunity. Using their surface bound T cell antigen receptors (TCRs), these cells screen millions of antigens presented by major histocompatibility complex (MHC) or MHC-like molecules. In other protein families, the dynamics of protein-protein interactions have important implications for protein function. Case studies of TCR:class I peptide-MHCs (pMHC-Is) structures have reported mixed results on whether the binding interfaces undergo conformational change during engagement and no robust statistical quantification has been done to generalise these results. Thus, it remains an open question of whether movement occurs in the binding interface that enables the recognition and activation of T cells.Methods: In this work, we quantify the conformational changes in the TCR:pMHC-I binding interface by creating a dataset of 391 structures, comprising 22 TCRs, 19 MHC alleles, and 79 peptide structures in both unbound (apo) and bound (holo) conformations.Results: In support of some case studies, we demonstrate that all complementarity determining region (CDR) loops move to a certain extent but only CDR3α and CDR3β loops modify their shape when binding pMHC-Is. We also map the contacts between TCRs and pMHC-Is, generating a novel fingerprint of TCRs on MHC molecules and show that the CDR3α tends to bind the N-terminus of the peptide and the CDR3β tends to bind the C-terminus of the peptide. Finally, we show that the presented peptides can undergo conformational changes when engaged by TCRs, as has been reported in past literature, but novelly show these changes depend on how the peptides are anchored in the MHC binding groove.Conclusions: Our work has implications in understanding the behaviour of TCR:pMHC-I interactions and providing insights that can be used for modelling Tcell antigen specificity, an ongoing grand challenge in immunology.
- 2 December 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1491656
Open AccessQuantifying conformational changes in the TCR:pMHC-I binding interface
Background: T cells form one of the key pillars of adaptive immunity. Using their surface bound T cell antigen receptors (TCRs), these cells screen millions of antigens presented by major histocompatibility complex (MHC) or MHC-like molecules. In other protein families, the dynamics of protein-protein interactions have important implications for protein function. Case studies of TCR:class I peptide-MHCs (pMHC-Is) structures have reported mixed results on whether the binding interfaces undergo conformational change during engagement and no robust statistical quantification has been done to generalise these results. Thus, it remains an open question of whether movement occurs in the binding interface that enables the recognition and activation of T cells.Methods: In this work, we quantify the conformational changes in the TCR:pMHC-I binding interface by creating a dataset of 391 structures, comprising 22 TCRs, 19 MHC alleles, and 79 peptide structures in both unbound (apo) and bound (holo) conformations.Results: In support of some case studies, we demonstrate that all complementarity determining region (CDR) loops move to a certain extent but only CDR3α and CDR3β loops modify their shape when binding pMHC-Is. We also map the contacts between TCRs and pMHC-Is, generating a novel fingerprint of TCRs on MHC molecules and show that the CDR3α tends to bind the N-terminus of the peptide and the CDR3β tends to bind the C-terminus of the peptide. Finally, we show that the presented peptides can undergo conformational changes when engaged by TCRs, as has been reported in past literature, but novelly show these changes depend on how the peptides are anchored in the MHC binding groove.Conclusions: Our work has implications in understanding the behaviour of TCR:pMHC-I interactions and providing insights that can be used for modelling Tcell antigen specificity, an ongoing grand challenge in immunology.
- Open Access
Early regional lymph node activation drives influenza vaccine responses in an ancestrally diverse cohort
Early in vivo dynamics of human immune-cell activation across regionally activated lymphoid tissue sites upon immunisation are poorly characterised in ancestrally diverse individuals. Here, we profiled draining and non-draining axillary lymph nodes (dLNs and ndLNs) by ultrasound-guided fine-needle aspiration (FNA) in 13 Black and Asian ancestry individuals, before and 3-7 days after vaccination with adjuvanted influenza vaccine. Draining but not ndLNs rapidly increased in size post-vaccination, by day 3, with distinct cellular dynamics determined through single cell multiomics. Dissecting LN cellular diversity into 42 lymphoid and non-lymphoid cell states, post-vaccination cell abundance changes were observed across all LNs, but dLNs were specifically characterised by CD4 + T follicular helper (CD4 + Tfh) cell expansion. Gene expression analysis revealed a dLN post-vaccination hub of multicellular activity defined by CD4 + Tfh signalling, cross-compartmental activation, translation, and enhanced antigen-presentation capacity. Thus, robust responses to intramuscular immunisation transcending ancestral inter-individual variation are elicited through temporal, anatomical and cellular lymphatic co-ordination with implications for vaccine design in ancestrally diverse populations. Summary: In this study of ancestrally diverse young adults, the temporarily co-ordinated response to an adjuvanted influenza vaccine at lymph nodes local to (draining) and distal from (non-draining) the injection site, reveals early regulation of cellular kinetics and anatomical hierarchy of the innate and adaptive immune responses.
Open AccessEarly regional lymph node activation drives influenza vaccine responses in an ancestrally diverse cohort
Early in vivo dynamics of human immune-cell activation across regionally activated lymphoid tissue sites upon immunisation are poorly characterised in ancestrally diverse individuals. Here, we profiled draining and non-draining axillary lymph nodes (dLNs and ndLNs) by ultrasound-guided fine-needle aspiration (FNA) in 13 Black and Asian ancestry individuals, before and 3-7 days after vaccination with adjuvanted influenza vaccine. Draining but not ndLNs rapidly increased in size post-vaccination, by day 3, with distinct cellular dynamics determined through single cell multiomics. Dissecting LN cellular diversity into 42 lymphoid and non-lymphoid cell states, post-vaccination cell abundance changes were observed across all LNs, but dLNs were specifically characterised by CD4 + T follicular helper (CD4 + Tfh) cell expansion. Gene expression analysis revealed a dLN post-vaccination hub of multicellular activity defined by CD4 + Tfh signalling, cross-compartmental activation, translation, and enhanced antigen-presentation capacity. Thus, robust responses to intramuscular immunisation transcending ancestral inter-individual variation are elicited through temporal, anatomical and cellular lymphatic co-ordination with implications for vaccine design in ancestrally diverse populations. Summary: In this study of ancestrally diverse young adults, the temporarily co-ordinated response to an adjuvanted influenza vaccine at lymph nodes local to (draining) and distal from (non-draining) the injection site, reveals early regulation of cellular kinetics and anatomical hierarchy of the innate and adaptive immune responses.
- Open Access
Quantifying conformational changes in the TCR:pMHC-I binding interface
T cells form one of the key pillars of adaptive immunity. Using their surface bound T cell antigen receptors (TCRs), these cells screen millions of antigens presented by major histocompatability complex (MHC) or MHC-like molecules. In other protein families, the dynamics of protein-protein interactions have important implications for protein function. Case studies of TCR:class I peptide-MHCs (pMHC-Is) structures have reported mixed results on whether the binding interfaces undergo conformational change during engagement and no robust statistical quantification has been done to generalise these results. It thus remains an open question if movement occurs in the binding interface that enables recognition and activation of T cells. In this work, we quantify the conformational changes in the TCR:pMHC-I binding interface by creating a dataset of 358 structures, comprising 25 TCRs, 20 MHC alleles, and 58 peptide structures in both unbound (apo) and bound (holo) conformations. In support of some case studies, we demonstrate that all complimentary determining region (CDR) loops move to a certain extent but only CDR3α and CDR3β loops modify their shape when binding pMHC-Is. We also map out the contacts between TCRs and pMHC-Is, generating a novel fingerprint of TCRs on MHC molecules and show that the CDR3α tends to bind the N-terminus of the peptide and the CDR3β tends to bind the C-terminus of the peptide. Finally, we show that the presented peptides can undergo conformational changes when engaged by TCRs, as has been reported in past literature, but novelly show these changes depend on how the peptides are anchored in the MHC binding groove. Our work has implications in understanding the behaviour of TCR:pMHC-I interactions and providing insights that can be used for modelling T cell antigen specificity, an ongoing grand challenge in immunology.
Open AccessQuantifying conformational changes in the TCR:pMHC-I binding interface
T cells form one of the key pillars of adaptive immunity. Using their surface bound T cell antigen receptors (TCRs), these cells screen millions of antigens presented by major histocompatability complex (MHC) or MHC-like molecules. In other protein families, the dynamics of protein-protein interactions have important implications for protein function. Case studies of TCR:class I peptide-MHCs (pMHC-Is) structures have reported mixed results on whether the binding interfaces undergo conformational change during engagement and no robust statistical quantification has been done to generalise these results. It thus remains an open question if movement occurs in the binding interface that enables recognition and activation of T cells. In this work, we quantify the conformational changes in the TCR:pMHC-I binding interface by creating a dataset of 358 structures, comprising 25 TCRs, 20 MHC alleles, and 58 peptide structures in both unbound (apo) and bound (holo) conformations. In support of some case studies, we demonstrate that all complimentary determining region (CDR) loops move to a certain extent but only CDR3α and CDR3β loops modify their shape when binding pMHC-Is. We also map out the contacts between TCRs and pMHC-Is, generating a novel fingerprint of TCRs on MHC molecules and show that the CDR3α tends to bind the N-terminus of the peptide and the CDR3β tends to bind the C-terminus of the peptide. Finally, we show that the presented peptides can undergo conformational changes when engaged by TCRs, as has been reported in past literature, but novelly show these changes depend on how the peptides are anchored in the MHC binding groove. Our work has implications in understanding the behaviour of TCR:pMHC-I interactions and providing insights that can be used for modelling T cell antigen specificity, an ongoing grand challenge in immunology.
- Open Access
- 18 June 2024
- Published by Springer Nature in Research Square
CELLeBT: exploring physical B cell-T cell clonal interactions through single-cell multi-omics
CELLeBT is a novel machine learning tool to decipher B cell-T cell interactions from single cell multi-omics data through leveraging droplets containing both a B cell receptor (BCR) and T cell receptor (TCR), thus containing both a B and a T cell. CELLeBT provides multiple types of information about B cell-T cell interactions, including the relative frequency of stable cellular interactions, the clonal nature and network of interactions, and the molecular drivers of these interactions as demonstrated through analysis of RCC and PDAC datasets, with unprecedented detail.
- 18 June 2024
- Published by Springer Nature in Research Square
Open AccessCELLeBT: exploring physical B cell-T cell clonal interactions through single-cell multi-omics
CELLeBT is a novel machine learning tool to decipher B cell-T cell interactions from single cell multi-omics data through leveraging droplets containing both a B cell receptor (BCR) and T cell receptor (TCR), thus containing both a B and a T cell. CELLeBT provides multiple types of information about B cell-T cell interactions, including the relative frequency of stable cellular interactions, the clonal nature and network of interactions, and the molecular drivers of these interactions as demonstrated through analysis of RCC and PDAC datasets, with unprecedented detail.
- Open Access
- 7 June 2024
- Published by Center for Open Science in SocArXiv
Widening gaps: the critical disparity in girls’ education globally
In this short manuscript, by highlighting some shocking numbers to reflect the depth of the critical disparity in girls education globally, we delve into the ramifications of gender discrimination, with a particular focus on the educational ban imposed on girls, and its subsequent effects on the physical and mental well-being of women. Afghanistan serves as a poignant example in our discussion, illustrating the profound issues engendered by the draconian policies of hardliner regimes.We urge policymakers, sports organizations, NGOs, and especially academic institutions to formulate immediate and effective strategies that can reinstate girls’ educational opportunities and dismantle entrenched gender discrimination. It is vital for girls and women, who have suffered under the yoke of gender apartheid worldwide, to witness global acknowledgement that their rights are immutable and transcend ethnicity or place of birth.
- 7 June 2024
- Published by Center for Open Science in SocArXiv
Open AccessWidening gaps: the critical disparity in girls’ education globally
In this short manuscript, by highlighting some shocking numbers to reflect the depth of the critical disparity in girls education globally, we delve into the ramifications of gender discrimination, with a particular focus on the educational ban imposed on girls, and its subsequent effects on the physical and mental well-being of women. Afghanistan serves as a poignant example in our discussion, illustrating the profound issues engendered by the draconian policies of hardliner regimes.We urge policymakers, sports organizations, NGOs, and especially academic institutions to formulate immediate and effective strategies that can reinstate girls’ educational opportunities and dismantle entrenched gender discrimination. It is vital for girls and women, who have suffered under the yoke of gender apartheid worldwide, to witness global acknowledgement that their rights are immutable and transcend ethnicity or place of birth.